TipRanks
Go Ultimate55% OFF

Compare Draegerwerk AG & Co. KGaA (DRW8) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:DRW8Draegerwerk AG & Co. KGaAEUR 74.80EUR 1.64B11.2822.95%―Unlock the DE:DRW8 analyst price target with TipRanks PremiumDE:DRW8Unlock the DE:DRW8 top-analyst price target with TipRanks Premium
DE:AFXCarl Zeiss MeditecEUR 34.78EUR 3.13B20.95-20.64%Moderate SellUnlock the DE:AFX analyst price target with TipRanks PremiumDE:DRW8 vs DE:AFXUnlock the DE:AFX top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 13.37EUR 832.23M16.63-20.44%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumDE:DRW8 vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:M3VMeVis Medical SolutionsEUR 20.20EUR 37.13M26.84-17.89%―Unlock the DE:M3V analyst price target with TipRanks PremiumDE:DRW8 vs DE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-562.501.91%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumDE:DRW8 vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.66-10.64%Strong BuyUnlock the DE:SHL analyst price target with TipRanks PremiumDE:DRW8 vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:DRW8Draegerwerk AG & Co. KGaA75.0013.6022.15%
DE:AFXCarl Zeiss Meditec34.84-7.21-17.15%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.47-2.92-17.84%
DE:M3VMeVis Medical Solutions20.20-3.51-14.80%
DE:SBSSTRATEC Biomedical23.951.777.97%
DE:SHLSiemens Healthineers AG43.40-4.27-8.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts